Study Comparing Postoperative Treatment After Surgical Decompression for Lumbar Spinal Stenosis.

NCT ID: NCT05312281

Last Updated: 2022-04-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

100 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-06-28

Study Completion Date

2025-12-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of the study is to assess the benefit of wearing a lumbar orthosis after surgery for spinal stenosis. It will be evaluated if a post-surgery immobilization for 6 weeks with a lumbar orthosis reduces early recurrence, increases walking distance, decreases significantly faster pain and pain medication after surgery

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Spinal stenosis and orthoses The study situation in this regard is very poor, high-quality level 1 studies are not available.

A study by Prateepavanich et al. from 2001 shows advantages in the therapy with lumbar orthoses in neurogenic spinal claudication in the context of conservative therapy (9). Regarding postoperative prescription, expert opinions have long diverged (10). Nevertheless, in a survey of North American spine surgeons, over 60% reported prescribing an orthosis postoperatively (11).

2 Aim of the study

The aim of this study is to show that patients after surgical decompression for lumbar spinal stenosis and patients after surgical sequestrectomy benefit from temporary postoperative immobilization using a lumbar orthosis.

To show that postoperative therapy with a lumbar orthosis prolongs walking distance and reduces early recurrence.

It will be shown that postoperative pain decreases significantly faster and thus pain medication can be reduced faster early postoperatively.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Spinal Stenosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Caregivers

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control group "without lumbar belt"

Control group "without lumbar belt"

Group Type NO_INTERVENTION

No interventions assigned to this group

Device : Lombastab immo. wear for 6 weeks post-surgery the Lombastab Immo

Lombastab immo. wear for 6 weeks post-surgery the Lombastab Immo

Group Type EXPERIMENTAL

Device : Lombastab immo. wear for 6 weeks post-surgery the Lombastab Immo

Intervention Type DEVICE

Wear for 6 weeks post-surgery

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Device : Lombastab immo. wear for 6 weeks post-surgery the Lombastab Immo

Wear for 6 weeks post-surgery

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Decompression with hemi-/ partial laminectomy, one. Laminectomy, and foraminotomy. Flavectomy with undercutting due to uni-and multi-segmental spinal stenosis.
* Age 20-80 years
* Pre-operative walking distance at least 100m
* Consent form signed by the patient

Exclusion Criteria

* Fusion surgery or recurrent surgery
* Tumors of the spine
* Cervical spinal stenosis or myelopathy
* Rheumatoid arthritis or similar autoimmune disease
* Infection - request for a pension
* Dyspnea due to heart failure with limited walking distance
* Peripheral Arterial Occlusive Disease (PAOD)-
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

SRH Gesundheitszentrum Bad Herrenalb

NETWORK

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Andreas Veihelmann, Prof

Role: STUDY_CHAIR

SRH Ges.-Zentrum Bad Herrenalb

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Klinikum Karlsruhe

Karlsruhe, , Germany

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Germany

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Uwe Spetzger, Prof

Role: CONTACT

+497219740

Andreas Veihelmann, Prof

Role: CONTACT

+497083926 ext. 4023

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Uwe Spetzger

Role: primary

+497219740

Andreas Veihelmann

Role: backup

+497083926

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

GBH-O1

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Clinical Outcome Measure at Stryker Spine
NCT06226272 NOT_YET_RECRUITING
Condition of Approval Study
NCT00517751 TERMINATED PHASE4
The NORDSTEN Studies/ The Spinal Stenosis Study
NCT02007083 ACTIVE_NOT_RECRUITING NA
The STEPS - Totalis™ Trial
NCT02079038 COMPLETED NA